| Literature DB >> 27011779 |
Iman A Basheti1, Salim A Hamadi2, Helen K Reddel3.
Abstract
OBJECTIVES: To explore whether an association exists between health care professionals' (HCPs) asthma knowledge and inhaler technique demonstration skills.Entities:
Keywords: Asthma; Attitudes; Health Knowledge; Interprofessional Relations; Jordan; Nebulizers and Vaporizers; Practice
Year: 2016 PMID: 27011779 PMCID: PMC4800018 DOI: 10.18549/PharmPract.2016.01.713
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Checklists for assessment of Accuhaler; Turbuhaler and pMDI technique in adults
| Accuhaler | |
| 1. Open inhaler | |
| 2. Push lever back completely | |
| 3. Exhale to residual volume | |
| 4. Exhale away from mouthpiece | |
| 5. Place mouthpiece between teeth and lips | |
| 6. Inhale forcefully and deeply | |
| 7. Hold breath for 5 seconds | |
| 8. Exhale away from mouthpiece | |
| 9. Close inhaler | |
| Turbuhaler | |
| 1. Remove cap from inhaler | |
| 2. Keep inhaler upright | |
| 3. Rotate grip around and then back until a click is heard | |
| 4. Exhale to residual volume | |
| 5. Exhale away from mouthpiece | |
| 6. Place mouthpiece between teeth and lips | |
| 7. Inhale forcefully and deeply | |
| 8. Hold breath for 5 seconds | |
| 9. Exhale away from mouthpiece | |
| pMDI | |
| 1. Remove mouthpiece cover | |
| 2. Shake the inhaler | |
| 3. Hold inhaler upright | |
| 4. Exhale to residual volume | |
| 5. Keep head upright or slightly tilted | |
| 6. Mouthpiece between teeth and lips | |
| 7. Inhale slowly and press canister | |
| 8. Continue slow and deep inhalation | |
| 9. Hold breath for 5 seconds | |
These checklists are in accordance to the literature.33, 34
Mean score (SD) for the Asthma Knowledge Questionnaire for HCPs (HQ) and Asthma Knowledge Questionnaire for consumers (CQ) for the participating HCPs (n=200).
| Profession | [ | ACC score (max 9) | TH score (max 9) | pMDI score (max 9) | [ | HQ mean (SD) score out of 17 | CQ mean (SD) score out of 12 |
|---|---|---|---|---|---|---|---|
| Specialist physician (n=10) | 6.80 (1.12) | 6.3 (1.7) | 6.4 (1.7) | 8.7 (0.67) | 0.86 (0.27) | 13.80 (0.79) | 11.00 (0.00) |
| General physician (n=18) | 5.62 (0.45) | 4.8 (0.51) | 5.0 (0.8) | 7.9 (0.94) | 0.70 (0.11) | 10.41 (2.17) | 9.89 (1.91) |
| Pharmacist (n=42) | 5.70 (0.69) | 5.2 (0.85) | 5.2 (1.10) | 7.7 (0.91) | 0.64 (0.11) | 9.43 (2.47) | 9.05 (1.36) |
| Pharmacist Assistant (n=10) | 6.40 (0.64) | 5.1 (0.88) | 5.6 (0.79) | 8.2 (1.2) | 0.63 (0.11) | 9.47 (2.36) | 8.87 (1.36) |
| Nurse (n=8) | 5.33 (0.33) | 4.9 (0.35) | 5.0 (0.41) | 7.2 (0.97) | 0.54 (0.88) | 7.95 (2.29) | 7.68 (1.69) |
| Respiratory therapist (n=10) | 5.93 (0.21) | 4.9 (0.32) | 4.9 (0.32) | 8.4 (0.68) | 0.71 (0.88) | 10.40 (1.96) | 10.30 (1.25) |
| All (n=129) | 5.86 (0.77) | 5.2 (0.9) | 5.2 (1.1) | 7.9 (1.0) | 0.65 (0.12) | 9.63 (2.59) | 9.12 (1.77) |
All participants (n=200) completed the HQ and CQ questionnaire, and 65% (n= 129) agreed to demonstrate their inhaler technique.
Average inhaler technique score is the average score over the three inhaler devices (max 9).
Asthma knowledge average score = ((HQ (score out of 17) + CQ (score out of 12))/29).
Significant differences were found between the HCPs (p<0.001, One way ANOVA). HQ= Health care professionals asthma knowledge questionnaire; CQ= Consumer asthma knowledge questionnaire; ACC= Accuhaler; TH= Turbuhaler; pMDI= Pressurized Metered Dose Inhaler.
Proportion of HCPs (n= 200) that answered correctly the questions in the Health Care Professional Asthma knowledge Questionnaire (HQ) and Consumer Asthma knowledge Questionnaire (CQ).
| Sp n=10 | GP n=46 | Phar n=79 | PA n=15 | N n=40 | RT n=10 | p-value | |
| 1. Asthma results from complex interactions among inflammatory cells, mediators, and other tissues in the airways ( | 100 | 97.8 | 97.5 | 80 | 70 | 100 | <0.001 |
| 2. Asthma can be triggered by aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) such as Nurofen ( | 100 | 95.7 | 82.3 | 86.7 | 47.5 | 70 | <0.001 |
| 3. After the patient has recovered from a severe asthma attack, he/she should be maintained on the same dose of oral corticosteroid permanently to control his/her condition ( | 100 | 84.8 | 68.4 | 46.7 | 57.5 | 100 | 0.014 |
| 4. The aim of asthma management is to empower health care professionals to take control of patient’s disease ( | 20 | 10.9 | 24.1 | 20 | 27.5 | 20 | 0.426 |
| 5. Asthma episodes are associated with variable airflow obstruction that is often reversible with treatment (T) | 100 | 93.5 | 77.2 | 93.3 | 80 | 100 | 0.194 |
| 6. All people with asthma should have a long acting beta2 agonist for symptoms relief ( | 100 | 76.1 | 48.1 | 73.3 | 40 | 60 | 0.001 |
| 7. The inflammatory process in asthma doesn’t cause permanent changes in the airways ( | 80 | 73.9 | 63.3 | 53.3 | 45 | 90* | 0.017 |
| 8. Multiple actuations of aerosol devices before inhaling from a spacer will result in more effective medication delivery ( | 100 | 30.4 | 40.5 | 40 | 45 | 20 | 0.009 |
| 9. The most common problem with dry powder inhaler (DPI) use is incorrectly coordinating drug release and inhalation ( | 80 | 17.4 | 25.3 | 53.3 | 22.5 | 30 | 0.007 |
| 10. It’s a good idea to give cough syrups during an asthma attack to treat asthma related cough ( | 100 | 82.6 | 59.5 | 86.7 | 50 | 80 | 0.012 |
| 11. The genetic predisposition for the Development of IgE mediated response to common aeroallergens isn’t a predisposing factor for developing asthma ( | 100 | 71.7 | 58.2 | 33.3 | 45 | 40 | 0.004 |
| 12. Inhaled non-steroidal anti-inflammatories such as sodium cromoglycate (Intal) are recommended as initial preventative therapy for children with frequent episodic to mild persistent asthma ( | 40 | 47.8 | 51.3 | 53.3 | 55 | 80 | 0.661 |
| 13. In some people with asthma, exercise induced symptoms may be the only manifestation of asthma ( | 100 | 87 | 57 | 53.3 | 65 | 60 | 0.012 |
| 14. When oral corticosteroids are initiated in an acute asthma attack, inhaled corticosteroids should be ceased to avoid any complications ( | 80 | 67.4 | 48.1 | 46.7 | 17.5 | 50 | <0.001 |
| 15. Dry Powder Inhalers (DPIs) require higher inspiratory flow rates than metered dose inhalers (pMDI) ( | 60 | 58.7 | 67.1 | 73.3 | 72.5 | 30 | 0.003 |
| 16. Only nebulizers can be used in children less than 2 years old who have asthma ( | 20 | 23.9 | 27.8 | 40 | 25 | 10 | 0.598 |
| 17. Unlike short acting bronchodilators, formoterol (Foradile, Oxis) effects usually last for 2 days ( | 100 | 50 | 46.2 | 53.3 | 37.5 | 100 | <0.001 |
| Sp n=10 | GP n=46 | Phar n=79 | PA n=15 | N n=40 | RT n=10 | P | |
| 1. You can become addicted to asthma medications if you use them all the time ( | 100 | 87 | 62 | 53.3 | 47.5 | 100 | <0.001 |
| 2. An asthma action plan can prevent hospitalizations due to asthma ( | 100 | 95.7 | 98.7 | 100 | 82.5 | 90 | 0.008 |
| 3. When you know that you are going to be exposed to something that triggers your asthma, you should take the recommended medication just before exposure ( | 80 | 84.8 | 74.7 | 86.7 | 45 | 90 | <0.001 |
| 4. When you know that you are going to be exposed to something that triggers your asthma, you should wait until you develop symptoms before taking medication ( | 100 | 69.6 | 73.4 | 73.3 | 52.5 | 90 | 0.027 |
| 5. Side effects are less likely with inhaled medications than with tablets ( | 100 | 89.1 | 83.5 | 93.3 | 67.5 | 100 | 0.017 |
| 6. With preventer medications, it does not matter if some doses are missed or if you go on and off them ( | 100 | 87 | 65.8 | 73.3 | 55 | 60 | 0.006 |
| 7. If you get a cold or flu, you should increase your asthma medications ( | 20 | 65.2 | 35.4 | 20 | 27.5 | 50 | 0.001 |
| 8. Some medications can trigger asthma attacks ( | 100 | 87 | 92.4 | 86.7 | 90 | 100 | 0.626 |
| 9. You should use ‘‘preventer medication’’ when you have an asthma attack ( | 100 | 45.7 | 46.8 | 46.7 | 55 | 80 | 0.047 |
| 10. Going from a cold to hot environment can trigger asthma, but going from a hot to cold environment does not trigger asthma ( | 100 | 87 | 90 | 86.7 | 77.5 | 100 | 0.225 |
| 11. Parents should give ‘‘reliever medication’’ to a child as soon as they recognize the first sign of asthma ( | 100 | 87 | 83.5 | 86.7 | 85 | 90 | 0.816 |
| 12. Blue puffer (Ventolin), Brown puffer (Flixotide) and Green puffer (Serevent) are called ‘‘preventer medication” ( | 100 | 84.8 | 79.9 | 80 | 80 | 80 | 0.718 |
Specialist (Sp); General Practitioner (GP); Pharmacist (Phar); Pharmacist Assistant (PA); Nurse (N); Respiratory Therapist (RT).
Summary of the final regression model (R2= 0.162, p<0.001) for the dependent variables Inhaler technique score (average for Accuhaler, Turbuhaler and pMDI) with its associated predictors, size and direction of the association (n= 200). Dependent variable: Inhaler technique score (average score for the devices: ACC, TH and pMDI)
| Associated predictors | Beta | t | P value |
|---|---|---|---|
| Profession of the HCP | -0.101 | -0.880 | 0.382 |
| Age | -0.058 | -0.232 | 0.818 |
| Gender | -0.043 | -0.360 | 0.720 |
| Years in practice | 0.199 | 0.853 | 0.396 |
| Place of work | 0.035 | 0.311 | 0.757 |
| Personal use of asthma devices | 0.048 | 0.460 | 0.647 |
| [ | 0.403 | 3.889 | <0.001 |
Asthma knowledge average score = ((HQ (score out of 17) + CQ (score out of 12))/29). HQ= Health care professionals asthma knowledge questionnaire; CQ= Consumer asthma knowledge questionnaire. “Beta” is the standardized regression coefficient, “Beta” values with their “p” values show whether each variable is making a statistically unique contribution to the model (P<0.05) or not. The t test given by the “T” value, tests the significance of each coefficient, it can determine the relative importance of each variable in the model (useful predictors usually have “t” values above 2 or below -2).